I have a question about this episode Dr. Peter Attia: Exercise, Nutrition, Hormones for Vitality & Longevity | Huberman Lab Podcast #85 and this GLP-1 Insights What does Andrew Huberman say about GLP-1s?
Sources:
In the episode featuring , discusses GLP-1 agonists, particularly noting them as significant in the context of obesity treatment. He compares the discussion around these medications to the past hype regarding fen-phen, an obesity drug withdrawn due to severe side effects. GLP-1 agonists are seen as promising, offering efficacy and greater safety compared to previous drugs. However, mentions that while these drugs facilitate fat loss, they also result in muscle loss, highlighting a critical consideration for users. Despite these downsides, Huberman expresses relief that there isn't anything catastrophic reported about these drugs thus far 1.
RELATED QUESTIONS
